Table 3
Frequency of HLA-DR17(3) and DQ2 in Mooren's ulcer patients and control populations
HLA
All
MU patients
Non-white
MU patients
Population frequencies
White
Indian
African
DR17(3)
10/12 (83%)
9/9 (100%)
23%
11% (4–19%)
10–20%
DQ2
10/12 (83%)
8/9 (89%)
33%
39% (36–45%)
17–19%